Watch for Daridorexant, a New Orexin Antagonist for Insomnia

June 2022

Daridorexant (Quviviq) will join a crowded list of Rx insomnia meds.

It's a me-too orexin antagonist...in the same family as suvorexant (Belsomra) and lemborexant (Dayvigo). All are C-IVs.

Daridorexant will be touted to help patients fall asleep faster...stay asleep longer...and feel less tired during the day. Reps will also say it can be used nightly...with no max duration.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Safety Improve Safe Use of Neuromuscular Blocking Agents
Transitions of Care Incorporate Discharge Med Rec Into Your Practice
Surgery Compare Zynrelef to Other Local Anesthetics
Cancer Help Overcome Barriers to Opioid Use for Cancer Pain
Aspirin Clear Up Confusion About Aspirin for CV Primary Prevention
Heart Failure Clarify New Heart Failure Terms and Management
Insomnia Watch for Daridorexant, a New Orexin Antagonist for Insomnia
Med Safety Be Aware of Rare PDE5 Inhibitor Risks
IBS Look for the Latest IBS-C Med, Tenapanor (Ibsrela)
Med Safety Keep Injectable Dyes Straight

Watch for Daridorexant, a New Orexin Antagonist for Insomnia

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents